Business Description

THC Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US60041A1025
Description
THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -91.63 | |||||
Debt-to-Equity | -0.14 | |||||
Debt-to-EBITDA | -0.24 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 71 | |||||
3-Year EPS without NRI Growth Rate | 69.4 | |||||
3-Year FCF Growth Rate | 19.6 | |||||
3-Year Book Growth Rate | -20.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 99.98 | |||||
14-Day RSI | 95.91 | |||||
6-1 Month Momentum % | -85.78 | |||||
12-1 Month Momentum % | -85.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32.9 | |||||
Shareholder Yield % | -5.99 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -1584.58 | |||||
ROIC % | -64.38 | |||||
ROC (Joel Greenblatt) % | -64021.05 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.28 | |||||
EV-to-EBITDA | -0.28 | |||||
EV-to-FCF | -2.98 | |||||
Earnings Yield (Greenblatt) % | -357.14 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:THCT
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
THC Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.09 | ||
Beta | -0.28 | ||
Volatility % | 155.49 | ||
14-Day RSI | 95.91 | ||
14-Day ATR ($) | 0.000012 | ||
20-Day SMA ($) | 0.0031 | ||
12-1 Month Momentum % | -85.78 | ||
52-Week Range ($) | 0.0026 - 0.0699 | ||
Shares Outstanding (Mil) | 34.15 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
THC Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
THC Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
THC Therapeutics Inc Frequently Asked Questions
What is THC Therapeutics Inc(THCT)'s stock price today?
The current price of THCT is $0.00. The 52 week high of THCT is $0.07 and 52 week low is $0.00.
When is next earnings date of THC Therapeutics Inc(THCT)?
The next earnings date of THC Therapeutics Inc(THCT) is .
Does THC Therapeutics Inc(THCT) pay dividends? If so, how much?
THC Therapeutics Inc(THCT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |